25 XP   0   0   10

EirGenix
Buy, Hold or Sell?

Let's analyse Eirgenix together

PenkeI guess you are interested in EirGenix. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of EirGenix. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about EirGenix

I send you an email if I find something interesting about EirGenix.

Quick analysis of Eirgenix (30 sec.)










What can you expect buying and holding a share of Eirgenix? (30 sec.)

How much money do you get?

How much money do you get?
NT$0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
NT$32.73
Expected worth in 1 year
NT$30.56
How sure are you?
42.9%

+ What do you gain per year?

Total Gains per Share
NT$-2.17
Return On Investment
-2.8%

For what price can you sell your share?

Current Price per Share
NT$77.00
Expected price per share
NT$71.60 - NT$85.20
How sure are you?
50%

1. Valuation of Eirgenix (5 min.)




Live pricePrice per Share (EOD)

NT$77.00

Intrinsic Value Per Share

NT$-94.13 - NT$-112.32

Total Value Per Share

NT$-61.40 - NT$-79.59

2. Growth of Eirgenix (5 min.)




Is Eirgenix growing?

Current yearPrevious yearGrowGrow %
How rich?$308.5m$328.8m-$11.9m-3.8%

How much money is Eirgenix making?

Current yearPrevious yearGrowGrow %
Making money-$7m-$889.6k-$6.1m-87.4%
Net Profit Margin-94.0%-6.9%--

How much money comes from the company's main activities?

3. Financial Health of Eirgenix (5 min.)




4. Comparing to competitors in the Biotechnology industry (5 min.)




  Industry Rankings (Biotechnology)  


Richest
#178 / 1016

Most Revenue
#323 / 1016

Most Profit
#484 / 1016

Most Efficient
#568 / 1016

What can you expect buying and holding a share of Eirgenix? (5 min.)

Welcome investor! Eirgenix's management wants to use your money to grow the business. In return you get a share of Eirgenix.

What can you expect buying and holding a share of Eirgenix?

First you should know what it really means to hold a share of Eirgenix. And how you can make/lose money.

Speculation

The Price per Share of Eirgenix is NT$77.00. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Eirgenix.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Eirgenix, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is NT$32.73. Based on the TTM, the Book Value Change Per Share is NT$-0.54 per quarter. Based on the YOY, the Book Value Change Per Share is NT$0.21 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is NT$0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Eirgenix.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 NT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per ShareNT$% of Price per Share
Usd Eps-0.04-0.1%-0.020.0%0.000.0%-0.010.0%-0.010.0%
Usd Book Value Change Per Share-0.030.0%-0.020.0%0.010.0%0.070.1%0.070.1%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.030.0%-0.020.0%0.010.0%0.070.1%0.070.1%
Usd Price Per Share3.10-3.28-3.17-3.16-3.16-
Price to Earnings Ratio-18.94--43.95-297.32-257.92-257.92-
Price-to-Total Gains Ratio-110.49--249.22--4,067.89--1,238.19--1,238.19-
Price to Book Ratio3.07-3.17-2.95-5.65-5.65-
Price-to-Total Gains Ratio-110.49--249.22--4,067.89--1,238.19--1,238.19-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share2.3716
Number of shares421
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.020.07
Usd Total Gains Per Share-0.020.07
Gains per Quarter (421 shares)-7.0530.32
Gains per Year (421 shares)-28.19121.26
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-28-380121111
20-56-660243232
30-85-940364353
40-113-1220485474
50-141-1500606595
60-169-1780728716
70-197-2060849837
80-226-2340970958
90-254-262010911079
100-282-290012131200

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.04.00.00.0%4.08.00.033.3%4.010.00.028.6%4.010.00.028.6%4.010.00.028.6%
Book Value Change Per Share0.04.00.00.0%5.07.00.041.7%6.08.00.042.9%6.08.00.042.9%6.08.00.042.9%
Dividend per Share0.00.04.00.0%0.00.012.00.0%0.00.014.00.0%0.00.014.00.0%0.00.014.00.0%
Total Gains per Share0.04.00.00.0%5.07.00.041.7%6.08.00.042.9%6.08.00.042.9%6.08.00.042.9%

Fundamentals of Eirgenix

About EirGenix

EirGenix Inc. operates as a contract development and manufacturing company in Taiwan and internationally. The company offers cell line development, process development, analytical and quality control, cGMP manufacturing mammalian and microbial system, and antibody-drug conjugate services. It is also involved in the development of EG12014/EGI014, a Trastuzumab biosimilar, indicated for the treatment of cancer and currently under biologics license application status; EG1206A, a Pertuzumab biosimilar, indicated for the treatment of cancer and currently under Phase I stage; EG13074, indicated for the treatment of cancer and currently under Preclinical stage; TSY0110(EG12043), an antibody-drug conjugate, indicated for the treatment of cancer and currently under Preclinical stage; EG12021, Bevacizumab biosimilar, indicated for the treatment of cancer and currently under Preclinical stage; and EG62054, a biosimilar, currently under Preclinical stage. In addition, the company manufactures and sells covid-19 antigen rapid test; and EG74032, a CRM197 carrier protein. EirGenix Inc. was incorporated in 2012 and is headquartered in New Taipei City, Taiwan.

Fundamental data was last updated by Penke on 2024-03-30 03:05:05.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
The company is making a huge loss.
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
The company is operating very inefficient.
The company is inefficient in keeping operating costs low.
Liquidity Details
 Compared to previous yearCompared to industry
The company is very able to pay all its short-term debts.
The company is very able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is very able to pay all its debts by selling its assets.
The company is very able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is fair priced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of EirGenix.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Eirgenix earns for each NT$1 of revenue.

  • Above 10% is considered healthy but always compare Eirgenix to the Biotechnology industry mean.
  • A Net Profit Margin of -88.9% means that NT$-0.89 for each NT$1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of EirGenix:

  • The MRQ is -88.9%. The company is making a huge loss. -2
  • The TTM is -94.0%. The company is making a huge loss. -2
Trends
Current periodCompared to+/- 
MRQ-88.9%TTM-94.0%+5.1%
TTM-94.0%YOY-6.9%-87.1%
TTM-94.0%5Y-44.9%-49.1%
5Y-44.9%10Y-44.9%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-88.9%-197.2%+108.3%
TTM-94.0%-210.4%+116.4%
YOY-6.9%-279.3%+272.4%
5Y-44.9%-436.8%+391.9%
10Y-44.9%-599.3%+554.4%
1.1.2. Return on Assets

Shows how efficient Eirgenix is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Eirgenix to the Biotechnology industry mean.
  • -3.6% Return on Assets means that Eirgenix generated NT$-0.04 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of EirGenix:

  • The MRQ is -3.6%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -2.0%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-3.6%TTM-2.0%-1.6%
TTM-2.0%YOY-0.2%-1.8%
TTM-2.0%5Y-1.6%-0.5%
5Y-1.6%10Y-1.6%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-3.6%-13.6%+10.0%
TTM-2.0%-12.9%+10.9%
YOY-0.2%-11.9%+11.7%
5Y-1.6%-14.2%+12.6%
10Y-1.6%-16.2%+14.6%
1.1.3. Return on Equity

Shows how efficient Eirgenix is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Eirgenix to the Biotechnology industry mean.
  • -4.1% Return on Equity means Eirgenix generated NT$-0.04 for each NT$1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of EirGenix:

  • The MRQ is -4.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -2.2%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-4.1%TTM-2.2%-1.8%
TTM-2.2%YOY-0.3%-2.0%
TTM-2.2%5Y-2.8%+0.6%
5Y-2.8%10Y-2.8%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ-4.1%-17.0%+12.9%
TTM-2.2%-16.1%+13.9%
YOY-0.3%-15.4%+15.1%
5Y-2.8%-20.0%+17.2%
10Y-2.8%-21.1%+18.3%

1.2. Operating Efficiency of EirGenix.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Eirgenix is operating .

  • Measures how much profit Eirgenix makes for each NT$1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Eirgenix to the Biotechnology industry mean.
  • An Operating Margin of 0.0% means the company generated NT$0.00  for each NT$1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of EirGenix:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-46.3%+46.3%
TTM-46.3%YOY-22.6%-23.6%
TTM-46.3%5Y-35.1%-11.1%
5Y-35.1%10Y-35.1%0.0%
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ--286.1%+286.1%
TTM-46.3%-224.4%+178.1%
YOY-22.6%-288.4%+265.8%
5Y-35.1%-475.2%+440.1%
10Y-35.1%-624.7%+589.6%
1.2.2. Operating Ratio

Measures how efficient Eirgenix is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology industry mean).
  • An Operation Ratio of 2.43 means that the operating costs are NT$2.43 for each NT$1 in net sales.

Let's take a look of the Operating Ratio trends of EirGenix:

  • The MRQ is 2.429. The company is inefficient in keeping operating costs low. -1
  • The TTM is 2.982. The company is inefficient in keeping operating costs low. -1
Trends
Current periodCompared to+/- 
MRQ2.429TTM2.982-0.554
TTM2.982YOY1.717+1.265
TTM2.9825Y2.078+0.904
5Y2.07810Y2.0780.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ2.4292.997-0.568
TTM2.9823.247-0.265
YOY1.7173.766-2.049
5Y2.0785.675-3.597
10Y2.0787.857-5.779

1.3. Liquidity of EirGenix.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Eirgenix is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology industry mean).
  • A Current Ratio of 9.78 means the company has NT$9.78 in assets for each NT$1 in short-term debts.

Let's take a look of the Current Ratio trends of EirGenix:

  • The MRQ is 9.779. The company is very able to pay all its short-term debts. +2
  • The TTM is 14.227. The company is very able to pay all its short-term debts. +2
Trends
Current periodCompared to+/- 
MRQ9.779TTM14.227-4.448
TTM14.227YOY11.253+2.975
TTM14.2275Y9.411+4.817
5Y9.41110Y9.4110.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ9.7793.930+5.849
TTM14.2274.251+9.976
YOY11.2535.436+5.817
5Y9.4116.045+3.366
10Y9.4116.363+3.048
1.3.2. Quick Ratio

Measures if Eirgenix is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Eirgenix to the Biotechnology industry mean.
  • A Quick Ratio of 1.07 means the company can pay off NT$1.07 for each NT$1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of EirGenix:

  • The MRQ is 1.069. The company is just able to pay all its short-term debts with the most liquid assets.
  • The TTM is 3.795. The company is very able to pay all its short-term debts with the most liquid assets. +2
Trends
Current periodCompared to+/- 
MRQ1.069TTM3.795-2.726
TTM3.795YOY1.061+2.734
TTM3.7955Y1.874+1.921
5Y1.87410Y1.8740.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ1.0693.629-2.560
TTM3.7954.065-0.270
YOY1.0615.397-4.336
5Y1.8745.993-4.119
10Y1.8746.277-4.403

1.4. Solvency of EirGenix.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Eirgenix assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Eirgenix to Biotechnology industry mean.
  • A Debt to Asset Ratio of 0.10 means that Eirgenix assets are financed with 10.3% credit (debt) and the remaining percentage (100% - 10.3%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of EirGenix:

  • The MRQ is 0.103. The company is very able to pay all its debts by selling its assets. +2
  • The TTM is 0.087. The company is very able to pay all its debts by selling its assets. +2
Trends
Current periodCompared to+/- 
MRQ0.103TTM0.087+0.015
TTM0.087YOY0.103-0.015
TTM0.0875Y0.203-0.116
5Y0.20310Y0.2030.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1030.332-0.229
TTM0.0870.334-0.247
YOY0.1030.268-0.165
5Y0.2030.366-0.163
10Y0.2030.390-0.187
1.4.2. Debt to Equity Ratio

Measures if Eirgenix is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Eirgenix to the Biotechnology industry mean.
  • A Debt to Equity ratio of 11.4% means that company has NT$0.11 debt for each NT$1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of EirGenix:

  • The MRQ is 0.114. The company is very able to pay all its debts with equity. +2
  • The TTM is 0.096. The company is very able to pay all its debts with equity. +2
Trends
Current periodCompared to+/- 
MRQ0.114TTM0.096+0.019
TTM0.096YOY0.114-0.019
TTM0.0965Y0.331-0.235
5Y0.33110Y0.3310.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
MRQ0.1140.381-0.267
TTM0.0960.390-0.294
YOY0.1140.334-0.220
5Y0.3310.434-0.103
10Y0.3310.466-0.135

2. Market Valuation of EirGenix

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every NT$1 in earnings Eirgenix generates.

  • Above 15 is considered overpriced but always compare Eirgenix to the Biotechnology industry mean.
  • A PE ratio of -18.94 means the investor is paying NT$-18.94 for every NT$1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of EirGenix:

  • The EOD is -14.513. Based on the earnings, the company is expensive. -2
  • The MRQ is -18.942. Based on the earnings, the company is expensive. -2
  • The TTM is -43.952. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-14.513MRQ-18.942+4.429
MRQ-18.942TTM-43.952+25.010
TTM-43.952YOY297.318-341.270
TTM-43.9525Y257.916-301.868
5Y257.91610Y257.9160.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-14.513-2.315-12.198
MRQ-18.942-2.560-16.382
TTM-43.952-2.664-41.288
YOY297.318-4.122+301.440
5Y257.916-6.258+264.174
10Y257.916-6.108+264.024
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of EirGenix:

  • The EOD is -11.362. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -14.830. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -23.058. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-11.362MRQ-14.830+3.468
MRQ-14.830TTM-23.058+8.228
TTM-23.058YOY-28.384+5.326
TTM-23.0585Y-57.275+34.217
5Y-57.27510Y-57.2750.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD-11.362-3.067-8.295
MRQ-14.830-3.251-11.579
TTM-23.058-3.545-19.513
YOY-28.384-5.595-22.789
5Y-57.275-8.315-48.960
10Y-57.275-8.708-48.567
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Eirgenix is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology industry mean).
  • A PB ratio of 3.07 means the investor is paying NT$3.07 for each NT$1 in book value.

Let's take a look of the Price to Book Ratio trends of EirGenix:

  • The EOD is 2.352. Based on the equity, the company is underpriced. +1
  • The MRQ is 3.070. Based on the equity, the company is fair priced.
  • The TTM is 3.169. Based on the equity, the company is fair priced.
Trends
Current periodCompared to+/- 
EOD2.352MRQ3.070-0.718
MRQ3.070TTM3.169-0.098
TTM3.169YOY2.951+0.218
TTM3.1695Y5.645-2.476
5Y5.64510Y5.6450.000
Compared to industry (Biotechnology)
PeriodCompanyIndustry (mean)+/- 
EOD2.3521.905+0.447
MRQ3.0702.111+0.959
TTM3.1692.095+1.074
YOY2.9512.836+0.115
5Y5.6453.443+2.202
10Y5.6453.794+1.851
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of EirGenix compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.910-0.544-40%0.208-538%2.338-139%2.338-139%
Book Value Per Share--32.73133.629-3%34.891-6%25.764+27%25.764+27%
Current Ratio--9.77914.227-31%11.253-13%9.411+4%9.411+4%
Debt To Asset Ratio--0.1030.087+18%0.103+0%0.203-49%0.203-49%
Debt To Equity Ratio--0.1140.096+20%0.1140%0.331-65%0.331-65%
Dividend Per Share----0%-0%-0%-0%
Eps---1.326-0.740-44%-0.094-93%-0.334-75%-0.334-75%
Free Cash Flow Per Share---1.694-1.289-24%-0.410-76%-0.574-66%-0.574-66%
Free Cash Flow To Equity Per Share---1.694-1.301-23%-0.308-82%1.203-241%1.203-241%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---112.323--------
Intrinsic Value_10Y_min---94.127--------
Intrinsic Value_1Y_max---3.757--------
Intrinsic Value_1Y_min---3.686--------
Intrinsic Value_3Y_max---17.004--------
Intrinsic Value_3Y_min---16.118--------
Intrinsic Value_5Y_max---37.140--------
Intrinsic Value_5Y_min---33.980--------
Market Cap23566004000.000-31%30758226000.00032632794500.000-6%31515704700.000-2%31374190627.371-2%31374190627.371-2%
Net Profit Margin---0.889-0.940+6%-0.069-92%-0.449-50%-0.449-50%
Operating Margin----0.4630%-0.2260%-0.3510%-0.3510%
Operating Ratio--2.4292.982-19%1.717+41%2.078+17%2.078+17%
Pb Ratio2.352-31%3.0703.169-3%2.951+4%5.645-46%5.645-46%
Pe Ratio-14.513+23%-18.942-43.952+132%297.318-106%257.916-107%257.916-107%
Price Per Share77.000-31%100.500106.625-6%102.975-2%102.513-2%102.513-2%
Price To Free Cash Flow Ratio-11.362+23%-14.830-23.058+55%-28.384+91%-57.275+286%-57.275+286%
Price To Total Gains Ratio-84.654+23%-110.490-249.219+126%-4067.887+3582%-1238.189+1021%-1238.189+1021%
Quick Ratio--1.0693.795-72%1.061+1%1.874-43%1.874-43%
Return On Assets---0.036-0.020-44%-0.002-93%-0.016-56%-0.016-56%
Return On Equity---0.041-0.022-45%-0.003-93%-0.028-31%-0.028-31%
Total Gains Per Share---0.910-0.544-40%0.208-538%2.338-139%2.338-139%
Usd Book Value--308537860.400316998566.500-3%328899578.700-6%242861779.600+27%242861779.600+27%
Usd Book Value Change Per Share---0.028-0.017-40%0.006-538%0.072-139%0.072-139%
Usd Book Value Per Share--1.0081.036-3%1.075-6%0.794+27%0.794+27%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.041-0.023-44%-0.003-93%-0.010-75%-0.010-75%
Usd Free Cash Flow---15970446.800-12146141.700-24%-3865107.400-76%-5414239.600-66%-5414239.600-66%
Usd Free Cash Flow Per Share---0.052-0.040-24%-0.013-76%-0.018-66%-0.018-66%
Usd Free Cash Flow To Equity Per Share---0.052-0.040-23%-0.009-82%0.037-241%0.037-241%
Usd Market Cap725832923.200-31%947353360.8001005090070.600-6%970683704.760-2%966325071.323-2%966325071.323-2%
Usd Price Per Share2.372-31%3.0953.284-6%3.172-2%3.157-2%3.157-2%
Usd Profit---12503044.400-7047101.600-44%-889658.000-93%-3164796.800-75%-3164796.800-75%
Usd Revenue--14062263.6007874428.100+79%11403830.900+23%10626961.400+32%10626961.400+32%
Usd Total Gains Per Share---0.028-0.017-40%0.006-538%0.072-139%0.072-139%
 EOD+3 -5MRQTTM+6 -26YOY+6 -265Y+11 -2110Y+11 -21

3.2. Fundamental Score

Let's check the fundamental score of EirGenix based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-14.513
Price to Book Ratio (EOD)Between0-12.352
Net Profit Margin (MRQ)Greater than0-0.889
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.069
Current Ratio (MRQ)Greater than19.779
Debt to Asset Ratio (MRQ)Less than10.103
Debt to Equity Ratio (MRQ)Less than10.114
Return on Equity (MRQ)Greater than0.15-0.041
Return on Assets (MRQ)Greater than0.05-0.036
Total4/10 (40.0%)

3.3. Technical Score

Let's check the technical score of EirGenix based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.184
Ma 20Greater thanMa 5085.080
Ma 50Greater thanMa 10089.304
Ma 100Greater thanMa 20094.907
OpenGreater thanClose80.000
Total1/5 (20.0%)



Latest Balance Sheet

Balance Sheet of 2023-12-31. Currency in TWD. All numbers in thousands.

Summary
Total Assets11,162,559
Total Liabilities1,145,096
Total Stockholder Equity10,017,463
 As reported
Total Liabilities 1,145,096
Total Stockholder Equity+ 10,017,463
Total Assets = 11,162,559

Assets

Total Assets11,162,559
Total Current Assets6,915,506
Long-term Assets4,247,053
Total Current Assets
Cash And Cash Equivalents 5,053,183
Short-term Investments 500,000
Net Receivables 256,026
Inventory 680,637
Total Current Assets  (as reported)6,915,506
Total Current Assets  (calculated)6,489,846
+/- 425,660
Long-term Assets
Property Plant Equipment 3,666,921
Long-term Assets Other 104,958
Long-term Assets  (as reported)4,247,053
Long-term Assets  (calculated)3,771,879
+/- 475,174

Liabilities & Shareholders' Equity

Total Current Liabilities707,165
Long-term Liabilities437,931
Total Stockholder Equity10,017,463
Total Current Liabilities
Accounts payable 79,556
Other Current Liabilities 2,937
Total Current Liabilities  (as reported)707,165
Total Current Liabilities  (calculated)82,493
+/- 624,672
Long-term Liabilities
Long term Debt 120,460
Capital Lease Obligations Min Short Term Debt344,707
Long-term Liabilities Other 6
Long-term Liabilities  (as reported)437,931
Long-term Liabilities  (calculated)465,173
+/- 27,242
Total Stockholder Equity
Total Stockholder Equity (as reported)10,017,463
Total Stockholder Equity (calculated)0
+/- 10,017,463
Other
Capital Stock3,060,516
Common Stock Shares Outstanding 305,990
Net Invested Capital 10,137,923
Net Working Capital 6,208,341
Property Plant and Equipment Gross 3,666,921



Balance Sheet

Currency in TWD. All numbers in thousands.

 Trend2023-12-312023-09-302023-06-302023-03-312022-12-312022-09-302022-06-302022-03-312021-12-312021-09-302021-06-302021-03-312020-12-312020-09-30
> Total Assets 
4,161,730
3,835,215
3,584,257
6,816,357
6,804,041
11,440,873
11,628,291
12,082,946
12,045,400
11,847,156
11,387,859
11,266,336
11,281,367
11,162,559
11,162,55911,281,36711,266,33611,387,85911,847,15612,045,40012,082,94611,628,29111,440,8736,804,0416,816,3573,584,2573,835,2154,161,730
   > Total Current Assets 
1,801,701
1,494,307
1,262,996
4,479,231
4,451,420
9,070,266
8,915,376
9,166,311
8,927,119
8,287,878
7,828,882
7,569,406
7,370,115
6,915,506
6,915,5067,370,1157,569,4067,828,8828,287,8788,927,1199,166,3118,915,3769,070,2664,451,4204,479,2311,262,9961,494,3071,801,701
       Cash And Cash Equivalents 
334,122
908,346
672,284
3,789,494
3,114,014
6,625,384
6,965,969
8,051,392
7,809,230
6,126,885
5,610,352
4,194,078
2,864,966
5,053,183
5,053,1832,864,9664,194,0785,610,3526,126,8857,809,2308,051,3926,965,9696,625,3843,114,0143,789,494672,284908,346334,122
       Short-term Investments 
720,660
114,520
3,308
1,230
641,644
1,664,865
1,027,465
0
0
1,000,000
1,000,000
2,200,000
3,200,000
500,000
500,0003,200,0002,200,0001,000,0001,000,000001,027,4651,664,865641,6441,2303,308114,520720,660
       Net Receivables 
522,610
231,422
243,166
320,271
227,120
260,844
271,264
373,212
338,312
32,782
274,876
225,874
37,680
256,026
256,02637,680225,874274,87632,782338,312373,212271,264260,844227,120320,271243,166231,422522,610
       Inventory 
195,959
204,899
265,222
322,062
409,668
475,518
603,337
694,524
733,729
739,463
894,851
905,779
895,480
680,637
680,637895,480905,779894,851739,463733,729694,524603,337475,518409,668322,062265,222204,899195,959
       Other Current Assets 
13,727
120,560
55,989
24,891
23,184
43,467
38,258
10,135
12,317
0
10,098
43,675
0
0
0043,67510,098012,31710,13538,25843,46723,18424,89155,989120,56013,727
   > Long-term Assets 
2,360,029
2,340,908
2,321,261
2,337,126
2,352,621
2,370,607
2,712,915
2,916,635
3,118,281
3,559,278
3,558,977
3,696,930
3,911,252
4,247,053
4,247,0533,911,2523,696,9303,558,9773,559,2783,118,2812,916,6352,712,9152,370,6072,352,6212,337,1262,321,2612,340,9082,360,029
       Property Plant Equipment 
2,174,003
2,168,492
2,150,977
2,157,323
2,165,426
2,184,563
2,278,316
2,382,392
2,537,900
2,934,178
3,029,637
3,189,323
3,386,009
3,666,921
3,666,9213,386,0093,189,3233,029,6372,934,1782,537,9002,382,3922,278,3162,184,5632,165,4262,157,3232,150,9772,168,4922,174,003
       Other Assets 
149,810
133,331
134,521
148,033
158,868
154,884
197,008
237,384
292,692
0
147,825
120,395
0
0
00120,395147,8250292,692237,384197,008154,884158,868148,033134,521133,331149,810
> Total Liabilities 
1,982,197
1,929,598
1,897,613
1,848,600
1,463,501
1,012,122
986,213
1,387,075
1,351,996
1,164,278
898,964
899,891
985,525
1,145,096
1,145,096985,525899,891898,9641,164,2781,351,9961,387,075986,2131,012,1221,463,5011,848,6001,897,6131,929,5981,982,197
   > Total Current Liabilities 
693,509
642,163
633,539
923,204
862,482
703,216
628,942
942,385
913,824
730,892
472,306
447,367
540,566
707,165
707,165540,566447,367472,306730,892913,824942,385628,942703,216862,482923,204633,539642,163693,509
       Short Long Term Debt 
0
0
0
0
194,960
127,070
30,796
0
0
0
0
0
0
0
000000030,796127,070194,9600000
       Accounts payable 
52,802
60,279
112,097
103,463
89,544
112,287
153,598
118,706
147,888
134,607
168,077
78,883
63,154
79,556
79,55663,15478,883168,077134,607147,888118,706153,598112,28789,544103,463112,09760,27952,802
       Other Current Liabilities 
379,633
261,944
236,395
371,481
389,962
286,239
284,615
652,353
560,851
3,104
161,525
200,210
3,014
2,937
2,9373,014200,210161,5253,104560,851652,353284,615286,239389,962371,481236,395261,944379,633
   > Long-term Liabilities 
1,288,688
1,287,435
1,264,074
925,396
601,019
308,906
357,271
444,690
438,172
433,386
426,658
452,524
444,959
437,931
437,931444,959452,524426,658433,386438,172444,690357,271308,906601,019925,3961,264,0741,287,4351,288,688
       Long term Debt 
962,229
918,066
917,263
607,239
285,248
0
39,560
120,460
120,460
120,460
120,460
120,460
120,460
120,460
120,460120,460120,460120,460120,460120,460120,46039,5600285,248607,239917,263918,066962,229
       Capital Lease Obligations Min Short Term Debt
328,149
323,541
319,884
315,030
310,234
307,542
338,487
348,948
342,453
338,584
331,845
359,575
352,101
344,707
344,707352,101359,575331,845338,584342,453348,948338,487307,542310,234315,030319,884323,541328,149
       Other Liabilities 
16,931
64,598
46,296
22,377
24,453
20,595
637
1,041
1,162
1,168
0
1,418
0
0
001,41801,1681,1621,04163720,59524,45322,37746,29664,59816,931
       Long-term Liabilities Other 
0
0
0
0
0
0
0
294
294
294
294
294
0
6
602942942942942940000000
> Total Stockholder Equity
2,179,533
1,905,617
1,686,644
4,967,757
5,340,540
10,428,751
10,642,078
10,695,871
10,693,404
10,682,878
10,488,895
10,366,445
10,295,842
10,017,463
10,017,46310,295,84210,366,44510,488,89510,682,87810,693,40410,695,87110,642,07810,428,7515,340,5404,967,7571,686,6441,905,6172,179,533
   Common Stock
2,060,994
2,063,751
2,064,102
2,436,287
2,442,924
3,003,845
3,029,129
3,036,262
3,040,684
3,043,358
0
3,046,672
0
0
003,046,67203,043,3583,040,6843,036,2623,029,1293,003,8452,442,9242,436,2872,064,1022,063,7512,060,994
   Retained Earnings Total Equity00000000000000
   Accumulated Other Comprehensive Income 00000000000000
   Capital Surplus 00000000000000
   Treasury Stock00000000000000
   Other Stockholders Equity 
-49,910
-41,189
-35,610
-29,746
-24,020
-77,546
-14,044
-18,041
-34,992
20,919
0
41,492
0
0
0041,492020,919-34,992-18,041-14,044-77,546-24,020-29,746-35,610-41,189-49,910



Balance Sheet

Currency in TWD. All numbers in thousands.




Cash Flow

Currency in TWD. All numbers in thousands.




Income Statement

Currency in TWD. All numbers in thousands.


Latest Income Statement (annual, 2023-12-31)

Gross Profit (+$)
totalRevenue1,022,653
Cost of Revenue-785,912
Gross Profit236,741236,741
 
Operating Income (+$)
Gross Profit236,741
Operating Expense-2,054,630
Operating Income-1,031,977-1,817,889
 
Operating Expense (+$)
Research Development952,290
Selling General Administrative316,428
Selling And Marketing Expenses0
Operating Expense2,054,6301,268,718
 
Net Interest Income (+$)
Interest Income134,471
Interest Expense-10,403
Other Finance Cost-0
Net Interest Income124,068
 
Pretax Income (+$)
Operating Income-1,031,977
Net Interest Income124,068
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-913,650-1,031,977
EBIT - interestExpense = -10,403
-915,208
-904,805
Interest Expense10,403
Earnings Before Interest and Taxes (EBIT)0-903,247
Earnings Before Interest and Taxes (EBITDA)0
 
After tax Income (+$)
Income Before Tax-913,650
Tax Provision-1,558
Net Income From Continuing Ops-915,208-915,208
Net Income-915,208
Net Income Applicable To Common Shares0
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses0
Total Other Income/Expenses Net0-124,068
 

Technical Analysis of Eirgenix
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Eirgenix. The general trend of Eirgenix is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Eirgenix's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of EirGenix.

The long score for the Support & Resistance is 0/1.
The longshort score for the Support & Resistance is -1/(-1 +1).

  • Around resistance: The price is trading arround resistance levels. This can be considered as a potential exit level. -1

The bullish price targets are: 78.00 < 81.10 < 85.20.

The bearish price targets are: 71.60.

Tweet this
EirGenix Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of EirGenix. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

EirGenix Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of EirGenix. The current macd is -2.76586324.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Eirgenix price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Eirgenix. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Eirgenix price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
EirGenix Daily Moving Average Convergence/Divergence (MACD) ChartEirGenix Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of EirGenix. The current adx is 32.96.

The long score for the Directional Movement Index (DMI) is 0/7.
The longshort score for the Directional Movement Index (DMI) is -4/(-7 +7).

  • PLUS_ID < MINUS_DI: The +DI line is below the -DI line. This indicates a bearish signal in the market, as the negative directional movement is currently stronger than the positive directional movement, showing that sellers have the upper hand. Market psychology suggests that traders are pessimistic, expecting further price decreases, and are more willing to sell Eirgenix shares, leading to potential downward momentum in its price. -1
  • PLUS_ID < MINUS_DI && ADX > 25 && ADX trending up: The ADX is above 25 and indicates a strong bearish trend. The ADX is trending up, so the bearish trend is strengthening.
EirGenix Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of EirGenix. The current sar is 85.89.

The long score for the Parabolic SAR is 0/1.
The longshort score for the Parabolic SAR is -1/(-1 +1).

  • Close < SAR: The price is below the SAR. It's generally considered a bearish signal. -1
EirGenix Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of EirGenix. The current rsi is 23.18. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 0/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
  • Trending down: The RSI is trending down. -1
EirGenix Daily Relative Strength Index (RSI) ChartEirGenix Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of EirGenix. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Eirgenix price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
EirGenix Daily Stochastic Oscillator ChartEirGenix Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of EirGenix. The current cci is -206.11983711.

The long score for the Commodity Channel Index (CCI) is 0/1.
The longshort score for the Commodity Channel Index (CCI) is -1/(-1 +1).

  • CCI < -100: The CCI is below -100, it indicates that the price is significantly below its average, suggesting a potential oversold condition. -1
EirGenix Daily Commodity Channel Index (CCI) ChartEirGenix Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of EirGenix. The current cmo is -58.97391773.

The long score for the Chande Momentum Oscillator (CMO) is 0/1.
The longshort score for the Chande Momentum Oscillator (CMO) is -1/(-1 +1).

  • CMO < 0: The CMO is below 0, the momentum of the price is negative, indicating a potential downtrend in the price. -1
EirGenix Daily Chande Momentum Oscillator (CMO) ChartEirGenix Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of EirGenix. The current willr is -95.90163934.

The long score for the Williams %R is 0/1.
The longshort score for the Williams %R is -1/(-1 +1).

  • WILLR < -80: The Williams %R is below -80. This indicates that the price is in oversold territory, suggesting a potential price correction or trend reversal to the upside. -1
EirGenix Daily Williams %R ChartEirGenix Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of EirGenix.

EirGenix Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of EirGenix. The current atr is 1.95089056.

EirGenix Daily Average True Range (ATR) ChartEirGenix Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of EirGenix. The current obv is 158,103,694.

EirGenix Daily On-Balance Volume (OBV) ChartEirGenix Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of EirGenix. The current mfi is 16.90.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
EirGenix Daily Money Flow Index (MFI) ChartEirGenix Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for EirGenix.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2023-11-20SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-11-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-11-22STOCH SHORT EXITThe %K line crosses above the %D line.
2023-11-24CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-11-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CCI LONG ENTRY SHORT CLOSE100 crossover to upside
2023-11-28SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH LONG EXITThe %K line crosses below the %D line.
2023-11-30CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2023-12-01MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2023-12-04MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2023-12-06WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-07STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-08STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-11CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-12STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-13STOCH LONG EXITThe %K line crosses below the %D line.
2023-12-14CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-15STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2023-12-19SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-21CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2023-12-25DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2023-12-26STOCH SHORT EXITThe %K line crosses above the %D line.
2023-12-28STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2023-12-29STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-02DMI LONG ENTRY SHORT CLOSEThe +DI crossed the -DI to the upside. The trend is reversing to an up trend.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
2024-01-03STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-04DMI SHORT ENTRY LONG CLOSEThe +DI crossed the -DI to the downside. The trend is reversing to a down trend.
2024-01-05STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-08STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-10BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-11STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-12STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-15STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-16WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-01-17STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-01-18STOCH SHORT EXITThe %K line crosses above the %D line.
2024-01-23SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-01-24MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-01-25MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
STOCH LONG EXITThe %K line crosses below the %D line.
2024-01-29SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
STOCH SHORT EXITThe %K line crosses above the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-01-30STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-02-02CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-02-05BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-02-16STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-19MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-02-21STOCH LONG EXITThe %K line crosses below the %D line.
CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-02-26SAR LONG ENTRY SHORT CLOSEThe price broke the SAR to the upside.
STOCH SHORT EXITThe %K line crosses above the %D line.
CMO LONG ENTRY SHORT CLOSEZero line crossover to upside
WILLR LONG ENTRY SHORT CLOSE-20 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-02-27STOCH LONG EXITThe %K line crosses below the %D line.
2024-02-29CMO SHORT ENTRY LONG CLOSEZero line crossover to downside
2024-03-05WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-03-06MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-03-07STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-08STOCH LONG EXITThe %K line crosses below the %D line.
WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-11SAR SHORT ENTRY LONG CLOSEThe price broke the SAR to the downside
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
2024-03-12STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-13MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-14STOCH LONG EXITThe %K line crosses below the %D line.
2024-03-18MFI SHORT ENTRY LONG CLOSE20 crossover to downside
2024-03-19STOCH SHORT EXITThe %K line crosses above the %D line.
2024-03-21MFI LONG ENTRY SHORT CLOSE20 crossover to upside
2024-03-22RSI LONG ENTRY SHORT CLOSE30 crossover to upside
2024-03-27MACD LONG ENTRY SHORT CLOSEThe MACD line crosses above the signal line.
2024-03-29STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-01STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-03STOCH LONG EXITThe %K line crosses below the %D line.
2024-04-08WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-09CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-10STOCH SHORT EXITThe %K line crosses above the %D line.
2024-04-11WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-12STOCH LONG EXITThe %K line crosses below the %D line.
CCI SHORT ENTRY LONG CLOSE-100 crossover to downside
2024-04-15MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-16STOCH SHORT EXITThe %K line crosses above the %D line.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
2024-04-17RSI LONG ENTRY SHORT CLOSE30 crossover to upside
ATR LONG ENTRY SHORT CLOSEPrice closed above (close + ATR).
2024-04-18WILLR SHORT ENTRY LONG CLOSE-80 crossover to downside
2024-04-19STOCH LONG EXITThe %K line crosses below the %D line.
BB LONG ENTRY SHORT CLOSEPrice closed below the lower band.
ATR SHORT ENTRY LONG CLOSEPrice closed below (close - ATR).
MFI SHORT ENTRY LONG CLOSE20 crossover to downside

6.3. Candlestick Patterns

EirGenix Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of EirGenix based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than5023.184
Ma 20Greater thanMa 5085.080
Ma 50Greater thanMa 10089.304
Ma 100Greater thanMa 20094.907
OpenGreater thanClose80.000
Total1/5 (20.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Eirgenix with someone you think should read this too:
  • Are you bullish or bearish on Eirgenix? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Eirgenix? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about EirGenix

I send you an email if I find something interesting about EirGenix.


Comments

How you think about this?

Leave a comment

Stay informed about EirGenix.

Receive notifications about EirGenix in your mailbox!